Skip to main content

FDA Approves Avastin

Avastin Approved for treatment for Metastatic Colorectal Cancer

Avastin (bevacizumab) is a recombinant humanized monoclonal IgG1 antibody which in combination with intravenous 5-fluorouracil-based chemotherapy, is indicated for first- or second-line treatment of patients with metastatic carcinoma of the colon or rectum.

Related articles

Avastin (bevacizumab) FDA Approval History

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.